Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 9, 2010
Pharmacy Choice - Pharmaceutical News - www.PicksThatMove.com: "Picks that move" Alerts, November 02, 2009: LMT, EW, ENZ, HOT, S and EMC - February 9, 2010

Pharmacy News Article

 11/2/09 - www.PicksThatMove.com: "Picks that move" Alerts, November 02, 2009: LMT, EW, ENZ, HOT, S and EMC

Picksthatmove.com Alerts include Lockheed Martin (NYSE: LMT); Edwards Lifesciences Corporation (NYSE: EW); Enzo Biochem Inc. (NYSE:ENZ); Starwood Hotels & Resorts Worldwide, Inc. (NYSE: HOT); Sprint (NYSE: S) and EMC Corporation (NYSE: EMC)

November 02, 2009 Lockheed Martin (NYSE: LMT) at $68.80 on a volume of 470,822 shares

In a press release on November 02, U.S. Navy Awards Lockheed Martin Nearly $10 Million to Design New Surface Ship Electronic Warfare System

SYRACUSE, N.Y., Nov 02, 2009 The U.S. Navy recently selected Lockheed Martin (NYSE: LMT) to provide its next-generation of electronic warfare (EW) systems for surface ships, which will significantly improve the Navy's ability to detect threats to the fleet.

Under an initial $9.9 million contract award, the company will produce a preliminary design for the Surface Electronic Warfare Improvement Program (SEWIP) Block 2 Upgrade by June 2010. The contract includes options, if exercised, totaling nearly $167 million.

About Lockheed Martin

Headquartered in Bethesda, Md., Lockheed Martin is a global security company that employs about 140,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The corporation reported 2008 sales of $42.7 billion.

November 02, 2009 Edwards Lifesciences Corporation (NYSE: EW) trading at $77.82 on a volume of 69,213 shares

In a press release on November 02, Edwards Lifesciences and DexCom Announce Receipt of CE Mark for Glucose Monitoring System

IRVINE, CA and SAN DIEGO, CA, Nov 02, 2009 Edwards Lifesciences Corporation (NYSE: EW), the leader in the sciences of heart valves and hemodynamic monitoring, and DexCom, Inc. (NASDAQ: DXCM), a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems, today announced the receipt of CE Mark for an automatic glucose monitoring system. Edwards and DexCom co-developed this new system, which is indicated for automatic, real-time monitoring and trending of blood glucose concentration in critically ill adults in the hospital environment. This CE Mark allows for commercialization of the system in the European Union and the countries in Asia and Latin America that recognize the CE Mark. Market evaluations of a first generation product are expected to begin in a limited number of European sites before the end of the year.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring, with more than five decades of experience in partnering with clinicians to develop life-saving innovations. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies, which are sold in approximately 100 countries. The company's global brands include Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

November 02, 2009 Enzo Biochem Inc. (NYSE:ENZ) trading at $5.62 on a volume of 21,418 shares.

In a press release out on November 02, Enzo Biochem Reports on Favorable Clinical Trial of EGS21 for Treatment of Non-Alcoholic Steatohepatitis

BOSTON, Nov 02, 2009 Enzo Biochem Inc. (NYSE:ENZ) announced today that favorable results of the Company's clinical trial for treatment of non-alcoholic steatohepatitis (NASH) were presented at the annual meeting of the American Association for the Study of Liver Diseases. The study was a randomized double blind placebo controlled format of EGS21, Enzo's orally administered beta glucosylceramide formulation, designed to evaluate safety and efficacy of the study drug in patients with NASH and its associated metabolic syndrome.

About Enzo

Enzo Biochem is engaged in the research, development, manufacture and licensing of innovative health care products and technologies based on molecular biology and genetic engineering techniques, and in providing diagnostic services to the medical community. Enzo's Life Sciences division develops, produces and markets proprietary labeling and detection products for gene sequencing, genetic analysis and immunological research among others. Its catalog of over 40,000 products serves the molecular biology, drug discovery and pathology research markets. The Company's therapeutic division is in various stages of clinical evaluation of its proprietary immune regulation medicines for uveitis and Crohn's disease and conducts pre-clinical research on several candidate compounds aimed at producing new mineral and organic bone, including technology that could provide therapy for osteoporosis and fractures, among other applications. Enzo's Clinical Labs division provides routine and esoteric reference laboratory services for physicians in the New York Metropolitan and New Jersey areas. Underpinning the Company's technology and operations is an extensive intellectual property estate in which Enzo owns or licenses over 230 patents worldwide, and has pending applications for over 200 more. For more information visit the Company's website www.enzo.com.

November 02, 2009 Starwood Hotels & Resorts Worldwide, Inc. (NYSE: HOT) last at $29.05 a volume of 1.97M shares

In a press release out on November 02, Starwood's Board Approves Annual Dividend of $0.20 Per Share

WHITE PLAINS, N.Y., Nov 02, 2009 Starwood Hotels & Resorts Worldwide, Inc. (NYSE: HOT) announced today that its Board of Directors has declared the Company's annual cash dividend of $0.20 per share. The dividend will be paid on January 14, 2010 to shareholders of record on December 31, 2009.

About Starwood Hotels & Resorts Worldwide, Inc.

Starwood Hotels & Resorts Worldwide, Inc. is one of the leading hotel and leisure companies in the world with 982 properties in 100 countries and approximately 145,000 employees at its owned and managed properties. Starwood(R) Hotels is a fully integrated owner, operator and franchisor of hotels and resorts with the following internationally renowned brands: St. Regis(R), The Luxury Collection(R), Sheraton(R), Westin(R), Four Points(R) by Sheraton, W(R), Le Meridien(R), and the recently announced Aloft(SM)and Element(SM). Starwood Hotels also owns Starwood Vacation Ownership, Inc., one of the premier developers and operators of high quality vacation interval ownership resorts. For more information, please visit www.starwoodhotels.com.

November 02, 2009 Sprint (NYSE: S) last at $2.97 on a volume of 11.70M shares

In a press release out on November 02, Sprint Offers Ultra-Mobile, Ultra-Affordable Computing with Dell Inspiron Mini 10 Powered by America's Most Dependable 3G Network

New netbook adds to Sprint's industry-leading device portfolio and offers affordable, blazing-fast mobile broadband access in an extremely portable package

MINNEAPOLIS, Nov 02, 2009 Sprint (NYSE: S) today unveiled Dell(TM) Inspiron(TM) Mini 10, the first netbook available from Sprint on America's most dependable 3G network(1). This companion PC offers blazing-fast Internet access in a convenient, affordable and portable package that can easily fit in a purse, backpack or briefcase. It is now available at select Sprint Stores throughout the Twin Cities for just $199.99 with activation on a Sprint Mobile Broadband plan and a two-year service agreement, after a $100 mail-in rebate.

About Sprint Nextel

Sprint Nextel offers a comprehensive range of wireless and wireline communications services bringing the freedom of mobility to consumers, businesses and government users. Sprint Nextel is widely recognized for developing, engineering and deploying innovative technologies, including two wireless networks serving more than 48 million customers at the end of the third quarter of 2009 and the first and only 4G service from a national carrier in the United States; industry-leading mobile data services; instant national and international push-to-talk capabilities; and a global Tier 1 Internet backbone. The company's customer-focused strategy has led to improved first call resolution and customer care satisfaction scores. For more information, visit www.sprint.com.

November 02, 2009 EMC Corporation (NYSE: EMC) trading at $16.64 on a volume of 5.55M shares

In a press release out on November 02, EMC Customers and Partners to Gather in Athens for Nearly Sold-Out Momentum Europe 2009

Group CIO of Eurobank EFG as Featured Speaker to Discuss How EMC Documentum Helped Reduce Costs and Improve Agility

HOPKINTON, Mass., Nov 02, 2009 EMC Corporation (NYSE: EMC), the world leader in information infrastructure solutions, today announced Momentum Europe 2009, which will be held November 9-12, 2009, at The Athenaeum Intercontinental Hotel in Athens, Greece. With more than 1,000 attendees and on track to sell out, Momentum Europe 2009 is the industry's largest gathering of customers, partners and industry experts in enterprise content management (ECM) and archiving outside of the Americas.

Momentum Europe attendees will converge in Athens to discuss and learn about market-leading innovations in the many facets of content management, archiving and compliance, such as: dynamic application composition, information governance and e-discovery, secure extended collaboration, intelligent capture, records management and customer communications management. This year's conference features a comprehensive agenda that includes more than 84 breakout sessions, in-depth technical presentations, product demonstrations and EMC fundamentals courses. A detailed agenda may be viewed at http://momentumeurope.com.

About EMC

EMC Corporation (NYSE: EMC) is the world's leading developer and provider of information infrastructure technology and solutions that enable organizations of all sizes to transform the way they compete and create value from their information. Information about EMC's products and services can be found at www.EMC.com.

www.picksthatmove.com is a leading stock website that provides free daily alerts on stocks that are moving up. www.picksthatmove.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at Info@picksthatmove.com

www.picksthatmove.com is an independent electronic publication that provides information on selected publicly traded companies. www.picksthatmove.com is not a registered investment advisor or broker-dealer. www.picksthatmove.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

((Comments on this story may be sent to info@m2.com))



(c) 2009 M2 COMMUNICATIONS

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Feb 09: The Essentials of Pharmacy Malpractice
Feb 11: Medication Safety in Pregnancy & Lactation
Feb 17: 2009 in Review: New Drugs, Dosage Forms, Indications and Warnings
Feb 21: Malpractice Case Studies in Pharmacy
Feb 22: Update on the Comprehensive Management of COPD
Click for entire Webinar Calendar

Special Announcement

Free Membership
Click Here to register to Win an iPod nano.
Rules and Regulations
Enjoy Free CE, Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comRxProHealth.comRxTechSchool.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415